Reaction
Shunt Occlusion reporting signals
As of the last recalculation, Shunt Occlusion appears in 500 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (PRR 133.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methoxy Polyethylene Glycol-Epoetin Beta | 33 | 133.2 | 133.6 |
| Iron Sucrose | 24 | 110.0 | 110.3 |
| Darbepoetin Alfa | 106 | 103.6 | 103.8 |
| Paricalcitol | 28 | 87.4 | 87.5 |
| Epoetin Alfa | 20 | 73.2 | 73.3 |
| Primidone | 15 | 63.2 | 63.3 |
| Calcitriol Capsules 0.25 Mcg | 23 | 50.0 | 50.1 |
| Calcitriol Capsules 0.5 Mcg | 23 | 50.0 | 50.1 |
| Calcitriol | 23 | 49.4 | 49.5 |
| Erythropoietin | 23 | 48.8 | 48.8 |
| Lubiprostone | 7 | 31.2 | 31.3 |
| Atomoxetine Hydrochloride | 14 | 25.2 | 25.2 |
| Palivizumab | 7 | 19.2 | 19.2 |
| Sevelamer Carbonate | 5 | 18.3 | 18.3 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 6 | 8.1 | 8.1 |
| Cinacalcet Hydrochloride | 8 | 7.2 | 7.2 |